Nitric oxide synthase 3 gene variants and colorectal cancer: A meta-analysis

Asian Pacific Journal of Cancer Prevention

Volumn 15, Issue 8, 2014, Pages 3811-3815

  Chen, Yang ^a   Li, Jie ^a   Guo, Yun ^a   Guo, Xiao Yun ^a  

^a GUANGXI MEDICAL UNIVERSITY   (China)

Author keywords

Colorectal cancer; Nitric oxide synthase 3; Polymorphism

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; NOS3 PROTEIN, HUMAN;

ADENOCARCINOMA; ALLELE; COLORECTAL TUMOR; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; HUMAN; META ANALYSIS; RISK; SINGLE NUCLEOTIDE POLYMORPHISM;

ADENOCARCINOMA; ALLELES; COLORECTAL NEOPLASMS; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; NITRIC OXIDE SYNTHASE TYPE III; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84902009517     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2014.15.8.3811     Document Type: Article

References (35)

1. Aguilar-Melero P, Ferrin G, Muntane J (2012). Effects of nitric oxide synthase-3 overexpression on post-translational modifications and cell survival in HepG2 cells. J Proteomics, 75, 740-755.
2. Ames BN (1983). Dietary carcinogens and anticarcinogens. Oxygen radicals and degenerative diseases. Science, 221, 1256-1264
3. Arikan S, Cacina C, Guler E, et al (2012). The effects of NOS3 Glu298Asp variant on colorectal cancer risk and progression in Turkish population. Mol Biol Rep, 39, 3245-3249.
4. Brankovic A, Brajuškovic G, Nikolic Z, et al (2013). Endothelial nitric oxide synthase gene polymorphisms and prostate cancer risk in Serbian population. Int J Exp Pathol, 94, 355-361.
5. Center MM, Jemal A, Smith RA, Ward E (2009). Worldwide variations in colorectal cancer. CA Cancer J Clin, 59, 366-378.
6. Conde MC, Ramirez-Lorca R, Lopez-Jamar JM, et al (2006). Genetic analysis of caveolin-1 and eNOS genes in colorectal cancer. Oncol Rep, 16, 353-359.
7. Chaleshi V, Haghighi MM, Savabkar S, et al (2013). Correlation between the EGF gene intronic polymorphism, rs2298979, and colorectal cancer. Oncol Lett, 6, 1079-1083.
8. Cunningham D, Atkin W, Lenz HJ, et al (2010). Colorectal cancer. Lancet, 375, 1030-1047.
9. Dan S, Bai L, Li-Jie W, Ting Z, Zhi-Yuan M (2013). Pharmacogenetic angiogenesis profiling for first-line chemotherapy in patients with advanced gastric cancer. Cancer Invest, 31, 390-396.
10. Egger M, Davey Smith G, Schneider M, Minder C (1997). Bias in meta-analysis detected by a simple, graphical test. BMJ, 315, 629-634.
11. Fatini C, Sofi F, Sticchi E, et al (2004). Influence of endothelial nitric oxide synthase gene polymorphisms (G894T, 4a4b, T-786C) and hyperhomocysteinemia on the predisposition to acute coronary syndromes. Am Heart J, 147, 516-521.
12. Fraga LR, Paludo FJ, Bos AJ, et al (2013). More severe clinical course of cardiovascular dysfunction in intensive care unit patients with the 894TT eNOS genotype. Genet Mol Res, 12, 562-568.
13. Funke S, Hoffmeister M, Brenner H, Chang-Claude J (2009a). Effect modification by smoking on the association between genetic polymorphisms in oxidative stress genes and colorectal cancer risk. Cancer Epidemiol Biomarkers Prev. 18, 2336-2338.
14. Funke S, Risch A, Nieters A, et al (2009b). Genetic polymorphisms in genes related to oxidative stress (GSTP1, GSTM1, GSTT1, CAT, MnSOD, MPO, eNOS) and survival of rectal cancer patients after radiotherapy. J Cancer Epidemiol, 2009, 302047.
15. Hildebrandt MA, Komaki R, Liao Z, et al (2010). Genetic variants in inflammation-related genes are associated with radiation-induced toxicity following treatment for non-small cell lung cancer. PLoS One, 5, 12402.
16. Ho-Pun-Cheung A, Assenat E, Bascoul-Mollevi C, et al (2011). A large-scale candidate gene approach identifies SNPs in SOD2 and IL13 as predictive markers of response to preoperative chemoradiation in rectal cancer. Pharmacogenomics J, 11, 437-443.
17. Ikeda S, Sasazuki S, Natsukawa S, et al (2008). Screening of 214 single nucleotide polymorphisms in 44 candidate cancer susceptibility genes: a case-control study on gastric and colorectal cancers in the Japanese population. Am J Gastroenterol, 103, 1476-1487.
18. Jang MJ, Jeon YJ, Kim JW, et al (2013). Association of eNOS polymorphisms (-786T>C, 4a4b, 894G>T) with colorectal cancer susceptibility in the Korean population. Gene, 512, 275-281.
19. Jemal A, Siegel R, Xu J, Ward E (2010). Cancer statistics, 2010. CA Cancer J Clin, 60, 277-300.
20. Kassab A, Msolly A, Lakhdar R, Gharbi O, Miled A (2014). Polymorphisms of glutathione-S-transferases M1, T1, P1 and susceptibility to colorectal cancer in a sample of the Tunisian population. Med Oncol, 31, 760.
21. Kelly RA, Balligand JL, Smith TW (1996). Nitric oxide and cardiac function. Circulation Research, 79, 363-380.
22. Kim YJ, Lee SJ, Kim JG, et al (2011). No association of the eNOS gene polymorphisms with survival in patients with colorectal cancer. Med Oncol, 28, 1075-1079.
23. Lau J, Ioannidis JP, Schmid CH (1997). Quantitative synthesis in systematic reviews. Ann Intern Med, 127, 820-826.
24. Luo L, Li DH, Wei SG, et al (2013). Polymorphisms in the endothelial nitric oxide synthase gene associated with recurrent miscarriage. Genet Mol Res, 12, 3879-3886.
25. Moochhala S, Chhatwal VJ, Chan ST, et al (1996). Nitric oxide synthase activity and expression in human colorectal cancer. Carcinogenesis, 17, 1171-1174.
26. Oh NJ, Ryu KY, Jung CN, Yi SY, Kim SR (2013). Expression of endothelial nitric oxide synthase in the uterus of patients with leiomyoma or adenomyosis. J Obstet Gynaecol Res, 39, 536-542.
27. Pfeifer GP, Denissenko MF, Olivier M, et al (2002). Tobacco smoke carcinogens, DNA damage and p53 mutations in smoking-associated cancers. Oncogene, 21, 7435-7451
28. Razavi HM, Hamilton JA, Feng Q (2005). Modulation of apoptosis by nitric oxide: implications in myocardial ischemia and heart failure. Pharmacol Ther, 106, 147-162.
29. Ryk C, Wiklund NP, Nyberg T, de Verdier PJ (2011). Polymorphisms in nitric-oxide synthase 3 may influence the risk of urinary-bladder cancer. Nitric Oxide, 25, 338-343.
30. Terrazzino S, La Mattina P, Masini L, et al (2012). Common variants of eNOS and XRCC1 genes may predict acute skin toxicity in breast cancer patients receiving radiotherapy after breast conserving surgery. Radiother Oncol, 103, 199-205.
31. Verim L, Toptas B, Ozkan NE, et al (2013). Possible relation between the NOS3 gene GLU298ASP polymorphism and bladder cancer in Turkey. Asian Pac J Cancer Prev, 14, 665-668.
32. Yao L, Fang F, Zhong Y, Yu L (2010). The association between two polymorphisms of eNOS and breast cancer risk: A meta-analysis. Breast Cancer Res Treat, 124, 223-227.
33. Yagihashi N, Kasajima H, Sugai S, et al (2000). Increased in situ expression of nitric oxide synthase in human colorectal cancer. Virchows Arch, 436, 109-114.
34. Yeh CC, Santella RM, Hsieh LL, Sung FC, Tang R (2009). An intron 4 VNTR polymorphism of the endothelial nitric oxide synthase gene is associated with early-onset colorectal cancer. Int J Cancer, 124, 1565-1571.
35. Zhao P, Dai M, Chen W, Li N (2010). Cancer trends in China. Jpn J Clin Oncol, 40, 281-285.